Precigen (PGEN)
NASDAQ:PGEN

Precigen (PGEN) Stock Price & Analysis

701 Followers

PGEN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.81 - $2.90
Previous Close$1.02
Volume642.59K
Average Volume (3M)2.32M
Market Cap
$247.68M
Enterprise Value$257.24M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-3.1
Beta1.14
May 11, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding252,194,713
10 Day Avg. Volume2,226,701
30 Day Avg. Volume2,315,834
Standard Deviation0.29
R-Squared0.13
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)5.39
Price to Sales (P/S)4.17
Price to Cash Flow (P/CF)61.50
P/FCF Ratio-3.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.98
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-6.78
Forecast
Price Target Upside824.55% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PGEN FAQ

What was Precigen’s price range in the past 12 months?
Precigen lowest stock price was $0.81 and its highest was $2.90 in the past 12 months.
    What is Precigen’s market cap?
    Currently, no data Available
    When is Precigen’s upcoming earnings report date?
    Precigen’s upcoming earnings report date is May 11, 2023 which is in 42 days.
      How were Precigen’s earnings last quarter?
      Precigen released its earnings results on Mar 06, 2023. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.01.
        Is Precigen overvalued?
        According to Wall Street analysts Precigen’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Precigen pay dividends?
          Precigen pays a Notavailable dividend of $0.24 which represents an annual dividend yield of N/A. See more information on Precigen dividends here
            What is Precigen’s EPS estimate?
            Precigen’s EPS estimate is -$0.09.
              How many shares outstanding does Precigen have?
              Precigen has 252,194,720 shares outstanding.
                What happened to Precigen’s price movement after its last earnings report?
                Precigen reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went up 17.391%.
                  Which hedge fund is a major shareholder of Precigen?
                  Among the largest hedge funds holding Precigen’s share is Caxton Associates LP. It holds Precigen’s shares valued at 118K.

                    ---

                    Precigen Stock Smart Score

                    The Precigen stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Precigen

                    Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

                    ---

                    Top 5 ETFs holding PGEN

                    Name
                    Market Value
                    Smart Score
                    iShares Core S&P Total U.S. Stock Market ETF
                    $101.37K
                    8
                    Schwab U.S. Broad Market ETF
                    $92.10K
                    8
                    iShares Russell 3000 ETF
                    $58.04K
                    8
                    BMO MSCI Innovation Index ETF
                    $1.57K
                    8
                    Dimensional US Core Equity Market ETF
                    $956.88
                    8
                    Up to five ETFs with an Outperform Smart Score that hold PGEN. The ETFs are listed according to market value of PGEN within the ETF

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Poseida Therapeutics
                    Arbutus Biopharma
                    Kodiak Sciences
                    Protagonist Therapeutics
                    89bio

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis